Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04626050 · ClinicalTrials.gov registry record · NA

General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19

A NA study of Post Traumatic Stress Disorder and Moral Injury, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04626050: Recruiting NA study of Post Traumatic Stress Disorder and Moral Injury, sponsored by Weill Medical College of Cornell University.

NCT04626050 is a NA study of Post Traumatic Stress Disorder and Moral Injury that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 120 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04626050, a NA study of Post Traumatic Stress Disorder and Moral Injury, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

It is expected that large numbers of healthcare workers will experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. The purpose of this study is to find interventions which are helpful in treating psychological distress in healthcare workers caring for COVID-19 patients. There are two phases of the study. All participants will take part in Phase I, which consists of 4 sessions over a two-week period of either a narrative writing intervention or a medical music intervention. Participants will be randomly assigned to the narrative writing intervention or medical music intervention. After Phase I, participants will be re-assessed. Healthcare workers who meet criteria for PTSD will be given the option to participate in Phase II of the study, in which they will be offered a choice between one of two evidence-based treatments for PTSD: Interpersonal Therapy (IPT) or Exposure Therapy (ET). Both treatments are comprised of ten 75-minute sessions scheduled twice weekly. Participants will be allowed to choose a preferred treatment in Phase II. After Phase II participants will complete a final assessment concluding the study. All interventions will be offered using distance technology.

Primary Outcome

Feasibility assessment will include recruitment defined as number of individuals interested in the intervention.

Interventions

  • BEHAVIORAL Medical Music
  • BEHAVIORAL Narrative Writing
  • BEHAVIORAL Prolonged Exposure Therapy
  • BEHAVIORAL Interpersonal Psychotherapy

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-01-20
Est. Completion 2028-04
Phase NA

What NCT04626050 shows while recruiting

NCT04626050 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 4 interventions - of which Medical Music is the first listed.

NCT04626050 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04626050 about?

NCT04626050 is a clinical study titled "General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19". It is expected that large numbers of healthcare workers will experience a broad range of psychological reactions and symptoms including anxiety, depression, moral distress, and trauma symptoms that will cause both significant suffering as well as occupational and social impairment. The purpose of th...

What is the current status of trial NCT04626050?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-01-20. Estimated completion is 2028-04.

What conditions does trial NCT04626050 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Moral Injury.

What interventions are being tested in trial NCT04626050?

The interventions under investigation include: Medical Music (BEHAVIORAL), Narrative Writing (BEHAVIORAL), Prolonged Exposure Therapy (BEHAVIORAL), Interpersonal Psychotherapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04626050?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04626050 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04626050's enrollment target sits among peer trials

120 96th of 262 higher than 158 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

  • NCT02164409 · 120 participants

    Changes Associated With H. Pylori and Gastric Carcinogenesis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04626050, the US trial registry maintained by the National Library of Medicine. NCT04626050 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.